Eventide Asset Management, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Eventide Asset Management, LLC

  • $5.67 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 21, 2019
SELL
$8.15 - $15.88 $308,127 - $600,375
-37,807 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$13.2 - $20.39 $3.71 Million - $5.73 Million
-281,193 Reduced 88.15%
37,807 $512,000
Q3 2018

Nov 14, 2018
BUY
$13.23 - $30.93 $298,998 - $699,018
22,600 Added 7.62%
319,000 $8.14 Million
Q2 2018

Aug 14, 2018
BUY
$16.73 - $20.35 $4.96 Million - $6.03 Million
296,400 New
296,400 $5.14 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $676M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email